SLU-PP-332
Fat LossERR agonist / small molecule researchExperimental
Pan-estrogen-related-receptor agonist studied as an exercise mimetic in mice (2023). Not a peptide and not FDA-approved.
For research use only.
Key Facts
- CAS
- 303760-60-3
- Molecular Weight (MW)
- 467.5 g/mol
- Half-life
- Not established
- Unit
- mcg
- Administration Route
- Oral
- Frequency
- Daily
- Last updated
- 8/23/2026
- Targets
- ERRαERRβERRγ
Overview
Pan-estrogen-related-receptor agonist studied as an exercise mimetic in mice (2023). Not a peptide and not FDA-approved.
Protocol
- Dosage Range
- 250-500 mcg
- Frequency
- Daily
- Cycle
- 4-12 weeks on, 4 off
- Administration Route
- Oral
- Reconstitution Guide
- N/A (capsule)
Science
Mechanism of Action
Activates ERRα/β/γ to increase mitochondrial respiration and fatty-acid oxidation, improving endurance and metabolic parameters in rodents.
Targets
ERRαERRβERRγ
Studies
- SLU-PP-332 exercise mimetic— Journal/year not available
Benefits
Exercise-mimetic research tool
Potential Side Effects
- No established human safety
References
- PMID 37788680External link · Year —